Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

NCT02183129 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Diclofenac
DRUG: Meloxicam

Sponsor

Boehringer Ingelheim